Navigation Links
Neurocrine Biosciences Announces Elagolix Scientific Presentations at the 67th Annual Meeting of the American Society for Reproductive Medicine
Date:9/27/2011

SAN DIEGO, Sept. 27, 2011 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that an elagolix podium presentation has been accepted for the scientific program at the 2011 Annual Meeting of the American Society for Reproductive Medicine, to be held October 15-19, 2011 in Orlando, Florida. This annual meeting draws over 4,000 experts from around the world to address current topics related to human reproduction.  

"We are very pleased to participate in the annual meeting of the American Society for Reproductive Medicine," said Chris O'Brien, M.D., Chief Medical Officer at Neurocrine. "Endometriosis is a leading cause of infertility in women and this scientific meeting brings together the world's thought leaders in obstetrics, gynecology, and endocrinology to discuss the latest advances in the field. We look forward to sharing our elagolix clinical data at this meeting."

An abstract from the Daisy Petal clinical study of elagolix for the treatment of endometriosis-associated pain will be presented at the 67th Annual Meeting of the American Society for Reproductive Medicine on Tuesday, October 18, 2011 at 4:15 pm during the abstract sessions. Bruce Carr, M.D. the Paul C. MacDonald Distinguished Chair in Obstetrics and Gynecology at University of Texas Southwestern Medical School will present "A Novel Oral GnRH Antagonist, Elagolix, is Effective For Reducing Endometriosis-Associated Pelvic Pain: Results of a 24-Week Randomized Study."

About Neurocrine Biosciences

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.  Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

In addition to historical facts, this press release may contain forward-looking statements that involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, and Company overall. In addition, the Company faces risks and uncertainties with respect to the Company's R & D pipeline including risk that the Company's clinical candidates will not be found to be safe and effective; and the other risks described in the Company's report on Form 10-K for the year ended December 31, 2010 and report on Form 10-Q for the quarter ended June 30, 2011. Neurocrine undertakes no obligation to update the statements contained in this press release after the date hereof.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
2. Neurocrine Biosciences Announces the Start of Phase II Study of Elagolix in Uterine Fibroids
3. Neurocrine Biosciences To Present at the Stifel Nicolaus 2011 Healthcare Conference
4. Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2011 Financial Results
5. Neurocrine Biosciences Announces elagolix Scientific Presentations at the 11th World Congress on Endometriosis
6. Neurocrine Biosciences to Present at the Jefferies 2011 Global Healthcare Conference
7. Neurocrine Biosciences to Present at the Deutsche Bank 36th Annual Healthcare Conference
8. Neurocrine Biosciences to Present at the 10th Annual Needham Healthcare Conference
9. Neurocrine Biosciences to Present at the Roth 23rd Annual OC Growth Stock Conference
10. Neurocrine Biosciences to Present at Citis 2011 Global Health Care Conference
11. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Hermann Health System has teamed up with Houston Rockets, ... one-of-a-kind experience to pediatric patients at Children,s Memorial ... video and Google Cardboard, Howard was able to visit ... patients and their families an unexpected, and energetically received, ... video . Memorial Hermann IRONMAN Sports Medicine ...
(Date:2/12/2016)... -- Aralez Pharmaceuticals Inc. (Nasdaq: ARLZ ) (TSX: ARZ), a ... the Nasdaq Closing Bell at the Nasdaq MarketSite in ... 4:00 p.m. ET on Tuesday, February 16, 2016 to ... Adams , will perform the honorary bell ringing ceremony ... A live webcast will be available at: https://new.livestream.com/nasdaq/live ...
(Date:2/12/2016)... , Maharashtra, February 12, 2016 ... research report titled Chronic Inflammation Global Clinical Trials ... snapshot of the global clinical trials landscape along ... trials by Region, Country (G7 & E7), Trial ... status and reviews top companies involved and enlists ...
Breaking Medicine Technology:
(Date:2/12/2016)... , ... February 12, 2016 , ... A lot has ... 35 years. A president has access to health and wellness resources most Americans could ... world, no single individual has a schedule as frenetic as the U.S. President. ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... growth in the field of long term care. With that, says Patrick Loughney, ... healthcare professionals in administrative roles in long term care environments. His company, which ...
(Date:2/12/2016)... Aliso Viejo, CA (PRWEB) , ... February 12, 2016 , ... ... by Pixel Film Studios. The new cartoon style themes are great for showcasing pictures, ... with completely customized scene generators, titles like introductions, lower thirds, transitions and a beautiful ...
(Date:2/11/2016)... ... February 12, 2016 , ... Fitbody Personal Training offers outdoor training classes ... way to get fit and healthy. Located in Phoenixville, PA, the classes are structured ... designed for horseback riders who want to lose weight and tone up. This class ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... (DMPG) will use the action analytics leader’s population health solutions, MDinsight® and ... clinical support to the Atlanta-area healthcare system. Details of the contract were not ...
Breaking Medicine News(10 mins):